Small Cell Lung Cancer (SCLC) Markets in the United States, EU5 and Japan (2017-2030): Epidemiology, Marketed & Emerging Drugs, Unmet Needs, Competitive Landscape

Source :: Plus Company Updates. May 20, 2020
Publication Year :: 2020
Abstract: DUBLIN: Research and Markets has issued the following news release: The 'Small Cell Lung Cancer (SCLC) - Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added [...]

Subjects :: Bristol-Myers Squibb Co. -- Forecasts and trends
AstraZeneca PLC -- Forecasts and trends
Durvalumab -- Reports -- Forecasts and trends
BCG -- Forecasts and trends -- Reports
Atezolizumab -- Reports -- Forecasts and trends
Nivolumab -- Reports -- Forecasts and trends
Carboplatin -- Reports -- Forecasts and trends
Small cell lung cancer -- Forecasts and trends -- Reports
Pembrolizumab -- Forecasts and trends -- Reports
Epidemiology -- Reports -- Forecasts and trends
Pharmaceutical industry -- Forecasts and trends
Dinutuximab -- Reports -- Forecasts and trends
Drugs
Lung cancer
Market trend/market analysis
General interest
News, opinion and commentary
Tecentriq (Medication) -- Reports
Imfinzi (Medication) -- Reports

Tools